Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney

Nephron - Physiology

Volumn 103, Issue 1, 2006, Pages

  Sampaio Maia, Benedita ^a   Moreira Rodrigues, Mónica ^b   Pestana, Manuel ^b,c  

^a Inst of Pharmacol and Therapeutics   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c University of Porto   (Portugal)

Author keywords

BIA 3 202; Catechol O methyltransferase; DOPAC; Homovanillic acid; Monamine oxidase; Natriuresis; Phosphaturia; Remnant kidney; Renal dopamine; Ro 411049

Indexed keywords

1 (3,4 DIHYDROXY 5 NITROPHENYL) 2 PHENYLETHANONE; 3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; HOMOVANILLIC ACID; MONOAMINE OXIDASE INHIBITOR; PHOSPHATE; RO 411049; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE URINE LEVEL; HIGH SODIUM INTAKE; MALE; METABOLITE; NATRIURESIS; NEPHRECTOMY; NONHUMAN; PHOSPHATE EXCRETION; PHOSPHATURIA; PRIORITY JOURNAL; RAT; RAT STRAIN; SODIUM EXCRETION; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; URINARY EXCRETION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; ENZYME INHIBITORS; KIDNEY; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEPHRECTOMY; PHOSPHATES; RATS; RATS, WISTAR; SODIUM;

EID: 33645994470     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090219     Document Type: Article

References (27)

1. Lee MR: Dopamine and the kidney: ten years on. Clin Sci (Lond) 1993;84:357-375.
2. Doggrell SA: The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs 2002;11:631-644.
3. Fernandes M, Soares-da-Silva P: Sequential Involvement of Monoamine Oxidase and Catechol-O-Methyltransferase in the Metabolism of Newly-Formed Dopamine in Rat Renal Tissues. Cardiovascular and Renal Actions of Dopamine. London, Pergamon Press, 1993, pp 21-30.
4. Aperia AC: Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000;62:621-647.
5. Pestana M, Jardim H, Serrao P, Soares-da-Silva P, Guerra L: Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease. Kidney Blood Press Res 1998;21:59-65.
6. Itskovitz HD, Wynn NC: Renal functional status and patterns of catecholamines excretion. J Clin Hypertens 1985;1:223-227.
7. Pestana M, Jardim H, Correia F, Vieira-Coelho MA, Soares-da-Silva P: Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 2001;16:53-59.
8. Pestana M, Santos J, Santos A, Coroas A, Correia F, Serrao P, Valbuena C, Soares-da-Silva P: Renal dopamine and salt sensitivity of blood pressure in IgA nephropathy. Kidney Blood Press Res 2004;27:78-87.
9. Sampaio-Maia B, Serrao P, Guimaraes JT, Vieira-Coelho MA, Pestana M: Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 2005;99:e46-e55.
10. Isaac J, Berndt TJ, Thothathri V, Tyce GM, Knox FG: Catecholamines and phosphate excretion by the remnant kidney. Kidney Int 1993;43:1021-1026.
11. Eklof AC, Holtback U, Sundelof M, Chen S, Aperia A: Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase. Kidney Int 1997;52:742-747.
12. 1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors. Kidney Int 2001;59:1683-1694.
13. Odlind C, Reenila I, Mannisto PT, Ekblom J, Hansell P: The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat. Pflügers Arch 2001;442:505-510.
14. Hansell P, Odlind C, Mannisto PT: Different renal effects of two inhibitors of catechol-O-methylation in the rat: entacapone and CGP 28014. Acta Physiol Scand 1998;162:489-494.
15. Odlind C, Goransson V, Reenila I, Hansell P: Regulation of dopamine-induced natriuresis by the dopamine-metabolizing enzyme catechol-O-methyltransferase. Exp Nephrol 1999;7:314-322.
16. Learmonth DA, Vieira-Coelho MA, Benes J, Alves PC, Borges N, Freitas, AP, Soares-da-Silva P: Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase. J Med Chem 2002;45:685-695.
17. Hansell P, Fasching A: The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int 1991;39:253-258.
18. Fernandes MH, Soares-da-Silva P: Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 1992;145:363-367.
19. Pestana M, Vieira-Coelho MA, Pinto-do OP, Fernandes MH, Soares-da-Silva P: Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat. Br J Pharmacol 1995;115:1349-1358.
20. Motulsky H, Spannard P, Neubig R: GraphPad Prism. San Diego, GraphPad Prism Software, 1994.
21. Fernandes MH, Pestana M, Soares-da-Silva P: Deamination of newly-formed dopamine in rat renal tissues. Br J Pharmacol 1991;102:778-782.
22. Pestana M, Soares-da-Silva P: Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices. Br J Pharmacol 1994;113:1269-1274.
23. Soares-da-Silva P, Pinto-do OP: Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation. Br J Pharmacol 1996;117:1187-1192.
24. Vieira-Coelho MA, Fernandes MH, Pestana M: Effect of type A and B monoamine oxidase inhibitors on the urinary excretion of dopamine, 5-hydroxytryptamine and amine metabolites. Br J Pharmacol 1993;36:153P.
25. Freestone S, Li Kam TC, Lee MR: Further Studies on Gludopa in Man: The Effect of the Monoamine Oxidase Inhibitor Selegiline. Oxford, Pergamon Press, 1993.
26. Chan YL: Cellular mechanisms of renal tubular transport of L-dopa and its derivatives in the rat: microperfusion studies. J Pharmacol Exp Ther 1976;199:17-24.
27. Buu NT, Duhaime J, Kuchel O: Effects of L-DOPA on the concentrations of free and sulfoconjugated catecholamines in plasma, cerebrospinal fluid, urine, and central and peripheral nervous system tissues of the rat. J Neurochem 1985;44:787-792.